The Fierce 15 is coming (soon)

I know many of you were waiting for the Fierce 15 today, but I'm going to ask for a few days grace. All the companies are selected and we will now roll out the whole package on Monday, which gives us some more time to make sure we deliver this package with all the ribbons and bows in place. I got some tremendous feedback from readers this year; really the best in the seven years that FierceBiotech has been doing its annual look at 15 biotech companies engaged in an exciting quest. And I'd like you to keep the cards and letters coming all year long. My work may be finished for the 2009 Fierce 15, but it's just beginning for our 2010 report. - John Carroll

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.